Construction and Characterization of Recombinant HEK Cell Over Expressing α4 Integrin

Shamsi Naderi Beni ¹, Shirin Kouhpayeh ², Zahra Hejazi ¹, Nahid Heidari Hafshejani ¹, Hossein Khanahmad ¹ *

Cited by CrossRef: 4

1- Mirian M, Kouhpayeh S, Shariati L, Boshtam M, Rahimmanesh I, Darzi L, Taghizadeh R, Jahanian-Najafabadi A, Khanahmad H. Generation of HBsAg DNA aptamer using modified cell-based SELEX strategy. Mol Biol Rep. 2021;48(1):139 [Crossref]

2- Mollasalehi N, Francois-Moutal L, Porciani D, Burke D, Khanna M. Aptamers Targeting Hallmark Proteins of Neurodegeneration. Nucleic Acid Therapeutics. 2022;32(4):235 [Crossref]

3- Kouhpayeh S, Hejazi Z, Boshtam M, Mirian M, Rahimmanesh I, Darzi L, Rezaei A, Shariati L, Khanahmad H. Development of α4 integrin DNA aptamer as a potential therapeutic tool for multiple sclerosis. J of Cellular Biochemistry. 2019;120(9):16264 [Crossref]

4- De Marco R, Greco A, Calonghi N, Dattoli S, Baiula M, Spampinato S, Picchetti P, De Cola L, Anselmi M, Cipriani F, Gentilucci L. Selective detection of α4β1 integrin (VLA‐4)‐expressing cells using peptide‐functionalized nanostructured materials mimicking endothelial surfaces adjacent to inflammatory sites. Peptide Science. 2018;110(5) [Crossref]